Lack of prognostic relevance of alterations in the epidermal growth factor receptor-transforming growth factor-α pathway in human astrocytic gliomas

Journal of Neurosurgery

Volumn 85, Issue 4, 1996, Pages 634-641

  Waha, Andreas ^a   Baumann, Axel ^a   Wolf, Helmut K ^a   Fimmers, Rolf ^a   Neumann, Jürgen ^a   Kindermann, Dietmar ^a   Astrahantseff, Kathy ^a   Blümcke, Ingmar ^a   Von Deimling, Andreas ^a   Schlegel, Uwe ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

astrocytoma; differential polymerase chain reaction; epidermal growth factor receptor; gene amplification; glioma; transforming growth factor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA;

ADULT; ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER SURVIVAL; FEMALE; GENE AMPLIFICATION; GLIOMA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; WORLD HEALTH ORGANIZATION;

EID: 10144241684     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1996.85.4.0634     Document Type: Article

References (48)

1. Agosti RM, Leuthold M, Gullick WJ, et al: Expression of the epidermal growth factor receptor in astrocytic tumours is specifically associated with glioblastoma multiforme. Virchows Arch A Pathol Anat Histopathol 420:321-325, 1992
2. Andreou J, George AE, Wise A, et al: CT prognostic criteria of survival after malignant glioma surgery. AJNR 4:488-490, 1983
3. Bigner SH, Burger CP, Wong AJ, et al: Gene amplification in malignant human gliomas: clinical and histopathologic aspects. J Neuropathol Exp Neurol 47:191-205, 1988
4. Bishop JM: The molecular genetics of cancer. Science 235: 305-311, 1987
5. Brodeur GM, Seeger RC, Schwab M, et al: Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224:1121-1124, 1984
6. Chang CH, Horton J, Schoenfeld D, et al: Comparison of post-operative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A Joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study. Cancer 52: 997-1007, 1983
7. Chen WS, Lazar CS, Lund KA, et al: Functional independence of the epidermal growth factor receptor from a domain required for ligand-induced internalization and calcium regulation. Cell 59:33-43, 1989
8. Collins VP: Amplified genes in human gliomas. Semin Cancer Biol 4:27-32, 1993
9. Collins VP, James CD: Molecular genetics of primary intracranial tumors. Curr Opin Oncol 2:666-672, 1990
10. Ekstrand AJ, James CD, Cavenee WK, et al: Genes for epidermal growth factor receptor, transforming growth factor α, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res 51:2164-2172, 1991
11. Ekstrand AJ, Sugawa N, James CD, et al: Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails. Proc Natl Acad Sci USA 89:4309-4313, 1992
12. Ferre F: Quantitative or semi-quantitative PCR: reality versus myth. PCR Methods Appl 2:1-9, 1992
13. Gehan EA, Walker MD: Prognostic factors for patients with brain tumors. Natl Cancer Inst Monogr 46:189-195, 1977
14. Gerosa MA, Talarico D, Fognani C, et al: Overexpression of N-ras oncogene and epidermal growth factor receptor gene in human glioblastomas. J Natl Cancer Inst 81:63-67, 1989
15. Humphrey PA, Gangarosa LM, Wong AJ, et al: Deletion-mutant epidermal growth factor receptor in human gliomas: effect of type II mutation on receptor function. Biochem Biophys Res Commun 178:1413-1420, 1991
16. Humphrey PA, Wong AJ, Vogelstein B, et al: Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma. Proc Natl Acad Sci 87:4207-4211, 1990
17. Hurtt MR, Moossy J, Donovan-Peluso M, et al: Amplification of epidermal growth factor receptor gene in gliomas: histopathology and prognosis. J Neuropathol Exp Neurol 51: 84-90, 1992
18. Jaros E, Perry RH, Adam L, et al: Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours. Br J Cancer 66:373-385, 1992
19. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York: Wiley & Sons, 1980
20. Kleihues P, Burger PC, Scheithauer BW (eds): Historical Typing of Tumors of the Central Nervous System, ed 2. Berlin: Springer-Verlag, 1993
21. Kraus J, Bolln C, Wolf HK, et al: TP53 alterations and clinical outcome in low grade astrocytomas. Genes Chrom Cancer 10:143-149, 1994
22. Laws ER Jr, Taylor WF, Clifton MB, et al: Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres. J Neurosurg 61:665-673, 1984
23. Libermann TA, Nusbaum HR, Razon N, et al: Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature 313:144-147, 1985
24. Libermann TA, Razon N, Bartal AD, et al: Expression of epidermal growth factor receptors in human brain tumors. Cancer Res 44:753-760, 1984
25. Massagué J: Transforming growth factor-α. A model for membrane-anchored growth factors. J Biol Chem 265: 21393-21396, 1990
26. Neubauer A, Neubauer B, He M, et al: Analysis of gene amplification in archival tissue by differential polymerase chain reaction. Oncogene 7:1019-1025, 1992
27. Pigott TJD, Robson DK, Palmer J, et al: Expression of epidermal growth factor receptor in human glioblastoma multiforme. Br J Neurosurg 7:261-265, 1993
28. Quigley MR, Maroon JC: The relationship between survival and the extent of the resection in patients with supratentorial malignant gliomas. Neurosurgery 29:385-389, 1991
29. Reifenberger G, Prior R, Deckert M, et al: Epidermal growth factor receptor expression and growth fraction in human tumours of the nervous system. Virchows Archiv A Pathol Anat Histopathol 414:147-155, 1989
30. Schlegel J, Merdes A, Stumm G, et al: Amplification of the epidermal-growth-factor-receptor gene correlates with different growth behaviour in human glioblastoma. Int J Cancer 56: 72-77, 1994
31. Schlegel U, Moots PL, Rosenblum MK, et al: Expression of transforming growth factor alpha in human gliomas. Oncogene 5:1839-1842, 1990
32. Schlegel U, Rosenfeld MR, Volkenandt M, et al: p53 gene mutations in primary lung tumors are conserved in brain metastases. J Neurooncol 14:93-100, 1992
33. Shapiro WR, Green SB, Burger PC, et al: Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group trial 8001. J Neurosurg 71:1-9, 1989
34. Shaw EG, Daumas-Duport C, Scheithauer BW, et al: Radiation therapy in the management of low-grade supratentorial astrocytomas. J Neurosurg 70:853-861, 1989
35. Slamon DJ, Clark GM, Wong SG, et al: Human breast cancer: correlation of relapse and survival with amplification of the her-2/neu oncogene. Science 235:177-182, 1987
36. Slebos RJC, Kibbelaar RE, Dalesio O, et al: K-Ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N Engl J Med 323:561-565, 1990
37. Ullrich A, Coussens L, Hayflick JS, et al: Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 309:418-425, 1984
38. Ullrich A, Schlessinger J: Signal transduction by receptor with tyrosine kinase activity. Cell 61:203-212, 1990
39. von Deimling A, Louis DN, von Ammon K, et al: Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme. J Neurosurg 77:295-301, 1992
40. von Deimling A, von Ammon K, Schoenfeld D, et al: Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol 3:19-26, 1993
41. Waha A, Rollbrocker B, Wiestler OD, et al: A PCR-based assay for the rapid detection of gene amplification in human tumors. Diag Mol Pathol 5:147-150, 1996
42. Walker MD, Green SB, Byar DP, et al: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303:1323-1329, 1980
43. Weinberg RA: Tumor suppressor genes. Science 254: 1138-1140, 1991
44. Winger MJ, Macdonald DR, Cairncross JG: Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma. J Neurosurg 71: 487-493, 1989
45. Wong AJ, Bigner SH, Bigner DD, et al: Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci USA 84:6899-6903, 1987
46. Wong AJ, Ruppert JM, Bigner SH, et al: Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc Natl Acad Sci USA 89:2965-2969, 1992
47. Wood JR, Green SB, Shapiro WR: The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group. J Clin Oncol 6:338-343, 1988
48. Yamazaki H, Fukui Y, Ueyama Y, et al: Amplification of the structurally and functionally altered epidermal growth factor receptor gene (c-erbB) in human brain tumors. Mol Cell Biol 8:1816-1820, 1988